We just received data on a new analyst forecast for $CLGN. Jason Kolbert from D. Boral Capital set a price target of 12.0 for CLGN.
To track analyst ratings and price targets for $CLGN, check out Quiver Quantitative's $CLGN forecast page.
Should you buy $CLGN?
Some analysts are better than others. To view the past performance of D. Boral Capital, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CLGN Price Targets
Multiple analysts have issued price targets for $CLGN recently. We have seen 2 analysts offer price targets for $CLGN in the last 6 months, with a median target of $11.5.
Here are some recent targets:
- Jason Kolbert from D. Boral Capital set a target price of $12.0 on 11/28/2025
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $11.0 on 08/21/2025
$CLGN Hedge Fund Activity
We have seen 8 institutional investors add shares of $CLGN stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HEIGHTS CAPITAL MANAGEMENT, INC removed 255,824 shares (-93.0%) from their portfolio in Q3 2025, for an estimated $688,166
- ANSON FUNDS MANAGEMENT LP removed 159,401 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $428,788
- VILLERE ST DENIS J & CO LLC added 41,850 shares (+7.7%) to their portfolio in Q3 2025, for an estimated $112,576
- AMH EQUITY LTD added 39,151 shares (+24.3%) to their portfolio in Q3 2025, for an estimated $105,316
- UBS GROUP AG removed 24,074 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $32,740
- RENAISSANCE TECHNOLOGIES LLC removed 19,700 shares (-47.4%) from their portfolio in Q3 2025, for an estimated $52,993
- PATHSTONE HOLDINGS, LLC removed 17,000 shares (-50.0%) from their portfolio in Q3 2025, for an estimated $45,730
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.